A 2.5 mg Tirzepatide dose on a 50 mg vial reconstituted with 1 mL of water is 5,000 mcg 50,000 mcg/mL 100 = 5 units
Over recent decades, the global prevalence of both diabetes and obesity has risen sharply, driven by unhealthy dietary habits, reduced physical activity, and environmental factors
When combined with a healthy diet and routine exercise, this treatment can help our adult patients lose up to 15% of their body weight
Building on the first proof that direct KRAS inhibition is feasible, current efforts are expanding beyond a single mutation toward broader strategies capable of targeting diverse KRAS variants and RAS-driven cancers
Bottom Line Semaglutide has a growing body of clinical evidence behind it, and for many people managing weight, type 2 diabetes, or cardiovascular risk, the long-term benefits can outweigh the risks